comparemela.com
  1. Home
  2. Live Updates
  3. Advanced Gastrointestinal Cancer Patients - Breaking News

Latest Breaking News On - Advanced gastrointestinal cancer patients - Page 1 : comparemela.com

Bold Therapeutics Presents Jaw-Dropping Interim Phase 2 Clinical Data for BOLD-100 in the Treatment of Advanced Colorectal Cancer at AACR 2023

/PRNewswire/ Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, announced positive interim.

British columbiaSouth koreaUnited statesTaiho lonsurfE russell mcallisterBayer stivargaAmerican society of clinical oncologyAmerican association for cancer researchBold therapeutics incAmerican associationCancer researchCirculating cytokine changes when administeredAdvanced gastrointestinal cancer patientsDose escalation studyPre treated advanced colorectal cancerInterim efficacy

Bold Therapeutics to Present Best-in-Class Phase 2 Metastatic Colorectal Cancer Data at AACR 2023

/PRNewswire/ Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, announced that it will present.

United statesBritish columbiaJim pankovichE russell mcallisterBold therapeutics incClinical developmentAmerican association for cancer researchAmerican associationCancer researchAnnual meetingDose escalation studyPre treated advanced colorectal cancerInterim efficacyCirculating cytokine changes when administeredAdvanced gastrointestinal cancer patientsBold therapeutics inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.